-
Federal
Obstructive sleep apnea and vascular disease
U.S. Department of Health & Human Services —
There is emerging evidence linking obstructive sleep apnea (OSA) to vascular disease, including hypertension. This relationship may be independent of co-morbidity,... -
Federal
Cardiac rehabilitation: a comprehensive review
U.S. Department of Health & Human Services —
Cardiac rehabilitation (CR) is a commonly used treatment for men and women with cardiovascular disease. To date, no single study has conclusively demonstrated a... -
Federal
Debate: The potential role of estrogen in the prevention of heart disease in women after menopause
U.S. Department of Health & Human Services —
Large numbers of observational studies have described a decrease in the incidence of cardiovascular disease in women taking hormone replacement therapy (HRT). The... -
Federal
A comparison of hospital readmission rates between two general physicians with different outpatient review practices
U.S. Department of Health & Human Services —
Background There has been a relentless increase in emergency medical admissions in the UK over recent years. Many of these patients suffer with chronic conditions... -
Federal
Long-term outcome after coronary stenting
U.S. Department of Health & Human Services —
The present review assesses the data on long-term outcome after coronary stenting. Histological, angiographical and intravascular imaging data have shown that the... -
Federal
Debate: Statins should be used in patients with heart failure
U.S. Department of Health & Human Services —
Treatment to prevent progression of heart failure has been targeted to reverse the consequences of heart failure and to a lesser extent the cause – the... -
Federal
Association of circulating
U.S. Department of Health & Human Services —
Background Chlamydia pneumoniae antigens, nucleic acids, or intact organisms have been detected in human atheroma. However, the presence of antibody does not predict... -
Federal
Clinical significance of cardiovascular dysmetabolic syndrome
U.S. Department of Health & Human Services —
Although diabetes mellitus is predominantly a metabolic disorder, recent data suggest that it is as much a vascular disorder. Cardiovascular complications are the... -
Federal
Anti-atherogenic effects of fibrates in type 2 diabetes
U.S. Department of Health & Human Services —
Type 2 diabetes is an increasing cause of premature coronary heart disease. Several trials with lipid-modifying therapy have included sufficient numbers of diabetics... -
Federal
Distal protection devices during percutaneous coronary and carotid interventions
U.S. Department of Health & Human Services —
Distal embolization of particulate matter complicates percutaneous coronary and peripheral interventions more often than had been recognized until recently. A number... -
Federal
Selected highlights from the 50
U.S. Department of Health & Human Services —
The recent scientific session of the American College of Cardiology (ACC), held in Orlando, provided a forum for ongoing cardiovascular clinical trials from around... -
Federal
Debate: Should statin be used in patients with heart failure?
U.S. Department of Health & Human Services —
Statins reduce mortality of patients with coronary artery disease (CAD). However, by protocol, trials have excluded patients with chronic heart failure. Since the... -
Federal
Therapeutic angiogenesis for cardiovascular disease
U.S. Department of Health & Human Services —
The identification of angiogenic growth factors, such as vascular endothelial growth factor and fibroblast growth factor, has fueled interest in using such factors to... -
Federal
Debate: Are surrogate end-point studies worth the effort?
U.S. Department of Health & Human Services —
Surrogate end-points of cardiovascular disease can provide useful information in cross-sectional, prospective and interventional studies. They provide information on... -
Federal
Comments on ALLHAT and doxazosin
U.S. Department of Health & Human Services —
This commentary has two purposes: to summarize the rationale, design and initial results of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack...